Cypress Asset Management Inc. TX lessened its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 27.0% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 11,443 shares of the pharmacy operator’s stock after selling 4,225 shares during the quarter. Cypress Asset Management Inc. TX’s holdings in Walgreens Boots Alliance were worth $675,000 at the end of the most recent quarter.
Several other institutional investors have also modified their holdings of WBA. American International Group Inc. lifted its stake in shares of Walgreens Boots Alliance by 781.9% during the 4th quarter. American International Group Inc. now owns 5,511,875 shares of the pharmacy operator’s stock worth $324,980,000 after purchasing an additional 4,886,896 shares during the period. JNE Partners LLP purchased a new position in shares of Walgreens Boots Alliance during the 4th quarter worth $29,881,000. Cullen Capital Management LLC lifted its stake in shares of Walgreens Boots Alliance by 205.2% during the 3rd quarter. Cullen Capital Management LLC now owns 746,010 shares of the pharmacy operator’s stock worth $41,262,000 after purchasing an additional 501,545 shares during the period. Pictet Asset Management Ltd. lifted its stake in shares of Walgreens Boots Alliance by 138.5% during the 3rd quarter. Pictet Asset Management Ltd. now owns 849,084 shares of the pharmacy operator’s stock worth $46,963,000 after purchasing an additional 493,061 shares during the period. Finally, Donaldson Capital Management LLC purchased a new position in shares of Walgreens Boots Alliance during the 3rd quarter worth $26,718,000. 60.38% of the stock is currently owned by institutional investors.
WBA has been the topic of a number of recent analyst reports. Pivotal Research reduced their price target on Walgreens Boots Alliance from $60.00 to $55.00 and set a “hold” rating on the stock in a research note on Wednesday, October 30th. Bank of America reissued a “sell” rating and set a $50.00 price target on shares of Walgreens Boots Alliance in a research note on Thursday, January 2nd. JPMorgan Chase & Co. downgraded Walgreens Boots Alliance from an “overweight” rating to a “neutral” rating and dropped their price objective for the stock from $73.00 to $63.00 in a report on Wednesday, October 23rd. BidaskClub downgraded Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a report on Thursday, January 23rd. Finally, Wells Fargo & Co downgraded Walgreens Boots Alliance from an “overweight” rating to an “equal weight” rating in a report on Wednesday, December 11th. Five equities research analysts have rated the stock with a sell rating and fifteen have assigned a hold rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $57.94.
Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Wednesday, January 8th. The pharmacy operator reported $1.37 EPS for the quarter, missing analysts’ consensus estimates of $1.40 by ($0.03). The firm had revenue of $34.34 billion for the quarter, compared to analyst estimates of $34.45 billion. Walgreens Boots Alliance had a return on equity of 21.76% and a net margin of 2.69%. The company’s quarterly revenue was up 1.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.46 earnings per share. As a group, analysts expect that Walgreens Boots Alliance Inc will post 5.86 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 12th. Stockholders of record on Wednesday, February 19th will be issued a dividend of $0.458 per share. The ex-dividend date is Tuesday, February 18th. This represents a $1.83 dividend on an annualized basis and a dividend yield of 3.47%. Walgreens Boots Alliance’s payout ratio is 30.55%.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Read More: The limitations of an equal weight rating
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.